|
CARMUSTINE |
L01AD01 |
SI
|
POM
|
|
|
|
VALID
|
|
BENDAMUSTINE |
L01AA09 |
SI
|
POM
|
|
|
|
VALID
|
|
MELPHALAN |
L01AA03 |
SI
|
POM
|
|
|
|
VALID
|
|
CHLORAMBUCIL |
L01AA02 |
SI
|
POM
|
|
|
|
VALID
|
|
CYCLOPHOSPHAMIDE |
L01AA01 |
SI
|
I
|
|
5363-I-247/03 |
03-04-2003 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
SI
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
SI
|
POM
|
18-08-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
SI
|
Not authorised
|
05-05-2025 |
|
|
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
J07BB02 |
SI
|
POM
|
05-10-2020 |
|
|
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
SI
|
POM
|
|
|
|
VALID
|
|
SIPAVIBART |
J06BD09 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006291 |
20-01-2025 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
SI
|
Not authorised
|
|
|
|
VALID
|
|
IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM. |
J06BA02 |
SI
|
POM
|
|
|
|
VALID
|
|
IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASCULAR ADM. |
J06BA01 |
SI
|
POM
|
|
|
|
VALID
|
|
BALOXAVIR MARBOXIL |
J05AX25 |
SI
|
POM
|
05-05-2025 |
|
|
VALID
|
|
TECOVIRIMAT |
J05AX24 |
SI
|
Not authorised
|
|
|
|
VALID
|
|
MARIBAVIR |
J05AX10 |
SI
|
POM
|
18-08-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE |
J05AR24 |
SI
|
POM
|
05-05-2025 |
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT |
J05AR22 |
SI
|
POM
|
|
|
|
VALID
|
|
DOLUTEGRAVIR AND RILPIVIRINE |
J05AR21 |
SI
|
POM
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND BICTEGRAVIR |
J05AR20 |
SI
|
POM
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND RILPIVIRINE |
J05AR19 |
SI
|
POM
|
|
|
|
VALID
|
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
J05AR17 |
SI
|
POM
|
|
|
|
VALID
|
|
LOPINAVIR AND RITONAVIR |
J05AR10 |
SI
|
POM
|
14-05-2018 |
5363-I-560/02 |
02-10-2002 |
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL AND RILPIVIRINE |
J05AR08 |
SI
|
POM
|
|
|
|
VALID
|
|
TENOFOVIR DISOPROXIL AND EMTRICITABINE |
J05AR03 |
SI
|
POM
|
|
|
|
VALID
|
|
GLECAPREVIR AND PIBRENTASVIR |
J05AP57 |
SI
|
POM
|
|
|
|
VALID
|
|
SOFOSBUVIR AND VELPATASVIR |
J05AP55 |
SI
|
POM
|
|
|
|
VALID
|
|
DASABUVIR |
J05AP09 |
SI
|
Not authorised
|
05-05-2025 |
|
|
VALID
|
|
TELAPREVIR |
J05AP02 |
SI
|
Not authorised
|
|
|
|
VALID
|
|
RALTEGRAVIR |
J05AJ01 |
SI
|
POM
|
|
|
|
VALID
|
|
OSELTAMIVIR |
J05AH02 |
SI
|
I
|
|
5363-I-637/02 |
08-11-2002 |
VALID
|
|
ZANAMIVIR |
J05AH01 |
SI
|
I
|
|
512/B-353/00 |
28-09-2000 |
VALID
|
|
DORAVIRINE |
J05AG06 |
SI
|
POM
|
31-05-2023 |
|
|
VALID
|
|
RILPIVIRINE |
J05AG05 |
SI
|
POM
|
|
|
|
VALID
|
|
TENOFOVIR ALAFENAMIDE |
J05AF13 |
SI
|
POM
|
|
|
|
VALID
|
|
ENTECAVIR |
J05AF10 |
SI
|
POM
|
|
|
|
VALID
|
|
EMTRICITABINE |
J05AF09 |
SI
|
Not authorised
|
|
|
|
VALID
|
|
ADEFOVIR DIPIVOXIL |
J05AF08 |
SI
|
Not authorised
|
05-05-2025 |
|
|
VALID
|
|
TENOFOVIR DISOPROXIL |
J05AF07 |
SI
|
POM
|
|
|
|
VALID
|
|
ABACAVIR |
J05AF06 |
SI
|
POM
|
29-01-2018 |
512/B-438/00 |
30-11-2000 |
VALID
|
|
LAMIVUDINE |
J05AF05 |
SI
|
I
|
|
512/B-255/98 |
09-07-1998 |
VALID
|
|
DIDANOSINE |
J05AF02 |
SI
|
Not authorised
|
05-05-2025 |
5363-I-393/05 |
07-07-2005 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
SI
|
POM
|
18-08-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|